← Eichor
Condition: Gram Negative Infections Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Gram Negative Infections

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administ
Phase 1/Phase 2 · 8 location(s) · SNIPR Biome Aps. · NCT06938867Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care
Phase 4 · 13 location(s) · Uppsala University · NCT07236944Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis
Phase 1 · 1 location(s) · Dalhousie University · NCT06827470A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Parti
Phase 2 · 8 location(s) · ModernaTX, Inc. · NCT07561294Cholera Control by Case-area Targeted Interventions (CATIs)
NA · 1 location(s) · International Centre for Diarrhoeal Disease Research, Bangla · NCT07685574A Multicenter Real-life Study of Disseminated Borreliosis Cases Occurring in Patients Receiving Anti-CD20 Treatment in F
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07343089Testing a Scalable Model of the Cholera Hospital-Based Intervention for 7 Days (CHoBI7)
NA · 1 location(s) · Johns Hopkins Bloomberg School of Public Health · NCT06498817Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection
NA · 1 location(s) · University of Washington · NCT05286931Transcranial Direct Current Stimulation for Post Treatment Lyme Disease
NA · 2 location(s) · Columbia University · NCT06915324Offering Routine and Rapid Point of Care (POC) Syphilis Testing in Pregnant Patients Presenting to the Emergency Departm
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06645106Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)
Phase N/A · 2 location(s) · MagIA Diagnostics · NCT07170748Preventative Intervention for Cholera for 7 Days
NA · 2 location(s) · Johns Hopkins Bloomberg School of Public Health · NCT05166850STI Testing to Enhance PrEP Use in Pregnancy
Phase 3 · 1 location(s) · Botswana Harvard AIDS Institute Partnership · NCT06919614Remote Sputum Collection in Cystic Fibrosis
Phase N/A · 3 location(s) · University of Pennsylvania · NCT06950892Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease
EARLY_Phase 1 · 1 location(s) · State University of New York - Upstate Medical University · NCT06611111Real World Study of Classic Infectious Disease
Phase N/A · 1 location(s) · Huashan Hospital · NCT04020536Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07683104A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Di
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00001539taVNS for Persistent Symptoms From Lyme Disease
NA · 1 location(s) · Columbia University · NCT05776251Short Infusion Versus Prolonged Infusion of Ceftolozane-tazobactam Among Patients with Ventilator Associated-pneumonia
Phase 3 · 1 location(s) · University Hospital, Toulouse · NCT03581370Modernizing Perinatal Syphilis Testing
NA · 9 location(s) · The University of Texas Health Science Center, Houston · NCT06082453Pediatric Pertussis in Ambulatory Settings
Phase N/A · 1 location(s) · Association Clinique Thérapeutique Infantile du val de Marne · NCT04807712Pharmacokinetic Analysis of Cefiderocol in Patients With Acute Burn Injuries
Phase 4 · 1 location(s) · University of Tennessee · NCT07465432Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Diseas
Phase 2 · 1 location(s) · Eveliqure Biotechnologies GmbH · NCT07049159Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections
Phase 2 · 23 location(s) · Pfizer · NCT05639647Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya
Phase 4 · 1 location(s) · Albert B. Sabin Vaccine Institute · NCT07487077Rickettsia Clearance Study
Phase 2/Phase 3 · 2 location(s) · Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit · NCT05972772Epidemiological, Clinical and Biological Characteristics of Human Anaplasmosis Cases in Alsace
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07312474A Cross-sectional Investigational Study to Evaluate the Sensitivity, Specificity, and Utility of the MedMira Inc. Multip
NA · 1 location(s) · MedMira Laboratories Inc. · NCT06586905
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.